EVMN
#2935
Evommune, Inc. Common Stock
13.4 2 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.07%
Variación mensual
+20.79%
Variación en los últimos 6 meses
-46.41%
Cambio anual
-22.52%
Cierres anteriores
13.4 3
Open
13.5 1
Mínimo
13.4 1
Máximo
13.5 5
Volumen
24
Financials
- Market Capitalization 487.04 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.53
Relación precio/flujo de caja
8.08
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2919 |  CCCC C4 Therapeutics, Inc. - Common Stock | 4.10 USD | -3.30% | +3.02% | +18.84% | +62.06% | 504.40 M USD | ||
| 2931 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 5.84 USD | -7.89% | -11.38% | +25.86% | +352.71% | 466.05 M USD | ||
| 2948 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.31 USD | +2.42% | +0.32% | +7.75% | +12.58% | 477.95 M USD | ||
| 2951 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.41 USD | -2.43% | -4.75% | -15.68% | +431.33% | 470.41 M USD |